The Centers for Disease Control and Prevention approved the addition of Johnson & Johnson’s newly designated Covid-19 vaccine to the arsenal of coronavirus prevention.
After a group of advisors voted in favour of adults in the United States having the one-dose vaccine, CDC Chief Rochelle P. Walensky gave the go-ahead on Sunday. With one recusal, the Advisory Committee on Immunization Practices voted 12-0 in favour.
Following FDA approval, J&J stated that it had begun shipping doses of its vaccine for allocation and distribution by the federal government. The doses are scheduled to arrive at vaccine providers in the United States in the coming days, with vaccines beginning shortly after.